Form 8-K - Current report:
SEC Accession No. 0001493152-24-041255
Filing Date
2024-10-16
Accepted
2024-10-16 10:30:17
Documents
30
Period of Report
2024-10-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41888
2 ex99-1.htm EX-99.1 12769
3 ex99-1_001.jpg GRAPHIC 752545
4 ex99-1_002.jpg GRAPHIC 1813117
5 ex99-1_003.jpg GRAPHIC 1170082
6 ex99-1_004.jpg GRAPHIC 1040464
7 ex99-1_005.jpg GRAPHIC 1095470
8 ex99-1_006.jpg GRAPHIC 1033741
9 ex99-1_007.jpg GRAPHIC 1099747
10 ex99-1_008.jpg GRAPHIC 1033295
11 ex99-1_009.jpg GRAPHIC 1120288
12 ex99-1_010.jpg GRAPHIC 1305997
13 ex99-1_011.jpg GRAPHIC 930736
14 ex99-1_012.jpg GRAPHIC 794566
15 ex99-1_013.jpg GRAPHIC 1037293
16 ex99-1_014.jpg GRAPHIC 1321360
17 ex99-1_015.jpg GRAPHIC 1010766
18 ex99-1_016.jpg GRAPHIC 973760
  Complete submission text file 0001493152-24-041255.txt   24348954

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE ogen-20241015.xsd EX-101.SCH 3018
20 XBRL LABEL FILE ogen-20241015_lab.xml EX-101.LAB 34240
21 XBRL PRESENTATION FILE ogen-20241015_pre.xml EX-101.PRE 24167
32 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3659
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241373666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)